Skip to main content
Fig. 2 | Breast Cancer Research

Fig. 2

From: Noninvasive imaging signatures of HER2 and HR using ADC in invasive breast cancer: repeatability, reproducibility, and association with pathological complete response to neoadjuvant chemotherapy

Fig. 2

Performance of image signature, ISHER2, in a the ROC analysis in both discovery and validation cohorts, b the calibration of ISHER2 between true probabilities and predicted probability with brier score, c, d the Bland–Altman plot of ISHER2 in test–retest cohort and perturbation cohorts

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us